Listed by the USPTO as MCKNIGHT, CIARA A
Tech Center 1600 • Art Units: 1637 1647 1655 1656
This examiner grants 62% of resolved cases
MCKNIGHT, CIARA A is assigned to Tech Center 1600 and art unit 1637. The record contains 78 resolved cases, with an allowance rate of 61.5%. The median time to allowance is 1152 days, showing an extended prosecution path for matters that reach allowance. The case base is limited, so the profile is best used as a directional reference.
The interview lift is 40.3%, associating interviews with a substantial improvement in allowance outcomes. Counsel may give interviews a prominent role in prosecution planning, particularly where a direct explanation can resolve technical or claim interpretation issues. The leading companies are Regeneron Pharmaceuticals Inc., CJ CheilJedang Corporation, and University of Massachusetts. The leading firms are ARRIGO, LEE, GUTTMAN & MOUTA-BELLUM LLP, BakerHostetler, and MCCARTER & ENGLISH, LLP BOSTON.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18717881 | CELL CRUSHING MONITORING METHOD, AND METHOD FOR PRODUCING POLYHYDROXYALKANOATES BY USING SAME | Non-Final OA | CJ CHEILJEDANG CORPORATION |
| 18482052 | NANOPORE TWEEZER APPROACH FOR PROTEIN KINASE ALLOSTERIC DRUG SCREENING | Non-Final OA | UNIVERSITY OF MASSACHUSETTS |
| 18310921 | METHODS FOR REDUCING LIPASE ACTIVITY | Final Rejection | Regeneron Pharmaceuticals, Inc. |
| 18115354 | CELL CULTURE METHODS FOR ANTIBODY PRODUCTION | Final Rejection | Regeneron Pharmaceuticals, Inc. |
| 18985811 | PROBIOTICS FOR MENTAL HEALTH | Non-Final OA | INTERNATIONAL N&H DENMARK APS |
| 18550967 | FUSION PROTEINS COMPRISING GG REPEAT SEQUENCES | Final Rejection | Numaferm GmbH |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy61.5% of resolved applications examined by Ciara A Mcknight were allowed (78 resolved cases), compared with 45.4% across Art Unit 1637 over the last five years.
This examiner's interview lift is +40.3 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Ciara A Mcknight took 1,152 days on average from filing to allowance.
Ciara A Mcknight examines applications in Art Unit 1637 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
